The North America Viral Inactivation Market was worth USD 120 million in 2016 and estimated to be growing at a CAGR of 13.1%, to reach USD 220 million by 2021. Viral Inactivation is a method in which viral cells are either killed or made inactive. It is mostly performed so that safety can be enhanced or to prevent contamination of desired products from viruses. The virus can be present in the final product, but only in an inactive form. All the inactivation techniques are done mainly in food and blood plasma industries to protect them from viruses.

Some of the methods in which Viral Inactivation is done are dry heating, solvent/detergent usage, lowering the pH, irradiation by UV rays and pasteurization among others Pasteurization is effective only if the proteins which are to be protected The North America Viral Inactivation Market have more thermal resistance than the viruses Viral Inactivation by solvents and detergents is the most used in the blood plasma industry However it is effective only for viruses present in lipid molecules The detergents/solvents disturbs the lipid molecule layers, thereby making them ineffective since they cannot survive without lipid molecules Similarly, lowering pH is effective when the molecules in the product are more resistant than viruses UV radiations cause viral inactivation by creating nucleic acid dimers, thus affecting life cycle and reproduction processes

View full report @ http://www.marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/

The North America Viral Inactivation market is driven by factors like swift growth in pharmaceuticals and biotechnology industries, focus of research and development industries in life sciences, increase of chronic diseases, launch of new drugs and growing support of government in biotechnology and pharmaceuticals sectors and among others The constraints faced by this market are less number of skilled workers and presence of strong consolidation

The North America Viral Inactivation market is segmented on the basis of method, product, application and end-user Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products Vaccines and therapeutics has the largest share in this segment Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others

Download free sample @ http://www.marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/request-sample

The North America market for Viral Inactivation is geographically segmented into United States, Canada and Mexico United States has the largest market share in the region It is also expected to be the fastest growing Factors such as growing support of government for biotechnology and pharmaceutical sectors, rising incidence of chronic diseases and growing focus of research and development in life sciences is expected to drive the growth of this market in the region

Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS SA, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc